Regeneron Pharmaceuticals
REGN
$978.21
Share price
-0.65%
Change (1 day)
30.26%
Change (1 year)
Categories
P/S ratio for Regeneron Pharmaceuticals (REGN)
P/S ratio as of May 2024 (TTM): 8.16
According to Regeneron Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.16359. At the end of 2023 the company had a P/S ratio of 7.29.
P/S ratio history for Regeneron Pharmaceuticals from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 7.29 | 13.02% |
| 2022 | 6.45 | 52.74% |
| 2021 | 4.23 | -30.35% |
| 2020 | 6.07 | 0.56% |
| 2019 | 6.03 | -0.56% |
| 2018 | 6.07 | -11.8% |
| 2017 | 6.88 | -13.65% |
| 2016 | 7.97 | -42.46% |
| 2015 | 13.8 | -7.11% |
| 2014 | 14.9 | 14.33% |
| 2013 | 13.0 | 7.97% |
| 2012 | 12.1 | 4.9% |
| 2011 | 11.5 | 79.99% |
| 2010 | 6.39 | 23.67% |
| 2009 | 5.17 | -15.68% |
| 2008 | 6.13 | -59.74% |
| 2007 | 15.2 | -26.38% |
| 2006 | 20.7 | 52.6% |
| 2005 | 13.6 | 358.56% |
| 2004 | 2.96 | -79.13% |
| 2003 | 14.2 | -62.2% |
| 2002 | 37.5 | -33.51% |
| 2001 | 56.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.10 | -49.80% | 🇺🇸 USA |
 Novartis NVS | 4.22 | -48.32% | 🇨🇭 Switzerland |
 Amgen AMGN | 6.07 | -25.63% | 🇺🇸 USA |
 Sanofi SNY | 2.49 | -69.49% | 🇫🇷 France |
 Biogen BIIB | 3.55 | -56.57% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | 9.43 | 15.55% | 🇺🇸 USA |